-
HCL Technologies
1,275.50 1,770.00(%) -
Shadowfax Technologies
203.85 98.60(%) -
Infosys
1,014.15 984.00(%) -
Bluestone Jewel
793.45 872.60(%) -
Bajaj Finance
1,002.00 788.40(%) -
HDFC Bank
737.20 726.75(%) -
Caliber Mining
538.15 538.15(%) -
E2E Networks
516.95 516.95(%) -
Coforge
1,488.00 1,988.90(%) -
ICICI Pru Life
495.55 459.60(%) -
SBI
1,018.00 1,234.80(%) -
AU Small Finance
1,015.00 1,090.40(%) -
SRF
2,697.50 3,257.95(%) -
Shriram Finance
992.75 566.40(%) -
Maruti Suzuki
13,498.95 17,371.60(%) -
B H E L
418.00 446.75(%) -
CG Power & Ind
839.25 525.50(%) -
Interglobe Aviat
4,886.70 3,894.80(%) -
Power Grid Corpn
285.65 250.05(%) -
Five-Star Bus.Fi
537.45 733.70(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 68403.0
- ISIN : INE552U01010
-
Today’s Low
2,664.00 -
Today’s High
2,820.00
-
Open
2,671.90 -
Perv Close
2,672.30 -
52W Low
1,561.00 -
52W High
2,890.30
Key Indicators
-
P/E(TTM)
42.40
-
Mar.Cap (₹Cr.)
2,886.35
-
Div & Yield %
0.00
-
Book Value(₹)
320.52
-
Debt-Equity Ratio
4.09
-
AGM Date
24-Jul-2026
-
EPS
65.50
-
P/E Ratio
42.40
Financials Ratios
-
Debt-Equity Ratio
0.45
-
Mar.Cap (₹Cr.)
2,886.35
-
RONW (%)
13.66
-
ROCE (%)
15.86
Score Board
-
Equity (₹ in Cr.)
10.38
-
BV (₹)
320.50
-
Sales( ₹ in Cr.)
503.06
-
NP (in Cr.)
67.96
-
NP Var(%)
70.0
-
Div%
0.0
-
CPS (₹)
84.60
-
EPS (₹)
65.50
-
Traded Value (₹ in Lakhs)
2,881.37
-
52 Week High
2,890.30
-
52 Week Low
1,561.00
-
Price BSE
2777.0
-
Price NSE
2,782.00
-
Market Capital( in Cr.)
2,881.37
-
P/C Ratio
32.80
-
P/E Ratio
42.40
-
Price Vs.BV
65.50
-
24-Jul-2026( 11:10)
Corporate News - Kwali... - Kwality Pharmaceuticals has ac...
-
19-May-2026( 12:59)
Results - Announcements - Kwali... - Net profit of Kwality Pharmace...
-
19-May-2026( 03:01)
Hot Pursuit - Kwali... - The company's consolidated net...
-
09-May-2026( 11:18)
Corporate News - Kwali... - Kwality Pharmaceuticals will...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 | 138.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 | 138.68 |
| Other Income | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 | 3.92 |
| Stock Adjustments | -1.17 | 1.48 | 3.20 | 2.51 | -0.09 | 5.52 |
| Total Income | 370.95 | 310.48 | 257.13 | 462.15 | 263.00 | 148.12 |
| EXPENDITURE : | ||||||
| Raw Materials | 181.31 | 154.66 | 113.27 | 203.11 | 165.50 | 92.59 |
| Power and Fuel Cost | 23.37 | 17.22 | 12.96 | 11.06 | 6.11 | 4.19 |
| Employee Cost | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 | 10.68 |
| Other Manufacturing Expenses | 3.32 | 6.75 | 4.98 | 4.57 | 3.78 | 2.85 |
| Selling and Administration Expenses | 37.31 | 30.74 | 32.57 | 48.71 | 41.12 | 19.43 |
| Miscellaneous Expenses | 2.03 | 9.32 | 17.97 | 0.72 | 1.16 | 0.33 |
| Employee Benefit Expenses | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 | 10.68 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 288.58 | 249.12 | 209.85 | 286.91 | 232.14 | 130.06 |
| Operating Profit | 82.37 | 61.37 | 47.29 | 175.24 | 30.86 | 18.05 |
| Interest | 9.88 | 10.39 | 6.61 | 2.92 | 2.62 | 2.52 |
| Gross Profit | 72.49 | 50.98 | 40.68 | 172.32 | 28.24 | 15.53 |
| Depreciation | 18.26 | 19.51 | 14.92 | 10.64 | 6.44 | 4.39 |
| Profit Before Tax | 54.23 | 31.47 | 25.76 | 161.68 | 21.80 | 11.14 |
| Current Tax | 15.93 | 7.92 | 6.16 | 41.35 | 6.22 | 3.03 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.59 | -0.44 | 0.14 | 0.27 | 0.16 | -0.32 |
| Reported Net Profit | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 | 8.43 |
| Extraordinary Items | 0.02 | -5.31 | -12.24 | 0.00 | -0.01 | 0.08 |
| Adjusted Net Profit | 39.87 | 29.29 | 31.71 | 120.05 | 15.43 | 8.35 |
| Adjustment below Net Profit | 0.01 | -0.06 | 0.00 | 0.08 | 0.00 | 0.00 |
| P & L Balance brought forward | 206.30 | 182.38 | 162.91 | 42.78 | 27.37 | 18.94 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 246.20 | 206.30 | 182.38 | 162.91 | 42.78 | 27.37 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 | 8.13 |
| Earnings Per Share(Adj)-Unit Curr | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 | 8.13 |
| Book Value | 255.44 | 216.98 | 193.93 | 175.17 | 59.47 | 44.62 |
| Book Value(Adj)-Unit Curr | 255.44 | 216.98 | 193.93 | 175.17 | 59.47 | 44.62 |
